Abstract: The use of collagen-based biomaterials in regenerative medicine has rapidly increased over the past decade. Over this period, a variety of collagen modification techniques have been ...

Over the past few decades, rapid progress in both tissue engineering and regenerative medicine has revolutionized approaches to tissue regeneration and ...

NurExone expects to initiate a Phase 1/2a clinical trial in 2026 (" 2026 SCI Trial ”) marking a major milestone in the advancement of regenerative therapies for central nervous system injuries.

The field of gynecological oncology has been significantly transformed by the advancements in molecular biology and precision medicine. These innovations ...

Candel Therapeutics, Inc. (NASDAQ:CADL) has secured FDA Regenerative Medicine Advanced Therapy (RMAT) designation for its ...

This nationwide academic grant invites eligible healthcare students to present visionary ideas about the future of aging, ...

Eden, the leading health platform connecting individuals with licensed providers and pharmacies focused on metabolic health, ...

CLEVELAND, OHIO - The Dr. John Fortuna Grant officially opens for applications, calling on dedicated undergraduate and graduate students in healthcare-related programs to share their forward-thinking ...

This content was created by our physicians and experts. Regenerative medicine uses biologic treatments to improve symptoms of certain orthopedic conditions and has the potential to enhance healing in ...

VTV.vn - Biotechnology is increasingly affirming its crucial role in improving public health and quality of life. In Viet Nam ...

The process of necrosis, a form of cell death, may represent one of the most promising ways to change the course of human aging, disease and even space travel, according to a new study.

The FDA's RMAT designation is intended to expedite the development and review of regenerative medicine therapies intended to treat, modify, reverse, or cure serious or life-threatening diseases where ...